6:30 PM
 | 
Dec 17, 2009
 |  BC Extra  |  Top Story

Almirall, Forest in LABA deal

Almirall S.A. (Madrid:ALM) partnered with Forest Laboratories Inc. (NYSE:FRX) to develop and commercialize Almirall's LAS100977 in the U.S. The once-daily long-acting adrenergic...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >